NPI: 1881961977 · LAS VEGAS, NV 89129 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 35,222 | $646K |
| 2019 | 43,781 | $847K |
| 2020 | 53,153 | $783K |
| 2021 | 48,641 | $682K |
| 2022 | 57,827 | $881K |
| 2023 | 27,919 | $904K |
| 2024 | 10,511 | $518K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 99,340 | 3,823 | $4.22M | |
| 90945 | 23,411 | 701 | $1.00M | |
| Q4081 | Epoetin alfa, 100 units esrd | 65,620 | 2,267 | $23K |
| J1756 | Iron sucrose injection | 16,413 | 2,370 | $8K |
| J0604 | Cinacalcet, esrd on dialysis | 400 | 116 | $6K |
| G0499 | Hepb screen high risk indiv | 2,011 | 516 | $152.09 |
| G0008 | Admin influenza virus vac | 262 | 132 | $81.99 |
| 90661 | 17 | 17 | $73.70 | |
| 83540 | 4,813 | 1,962 | $0.00 | |
| 83970 | 4,896 | 1,966 | $0.00 | |
| 85041 | 5,988 | 2,392 | $0.00 | |
| 85048 | 5,943 | 2,378 | $0.00 | |
| 82108 | 1,636 | 640 | $0.00 | |
| J0887 | Epoetin beta esrd use | 1,811 | 511 | $0.00 |
| 85045 | 16 | 12 | $0.00 | |
| 90662 | 35 | 16 | $0.00 | |
| 82728 | 4,246 | 1,731 | $0.00 | |
| A4657 | Syringe w/wo needle | 6,815 | 2,488 | $0.00 |
| J1270 | Injection, doxercalciferol | 28,646 | 1,398 | $0.00 |
| 82746 | 394 | 139 | $0.00 | |
| 83550 | 3,362 | 1,550 | $0.00 | |
| 82306 | 908 | 332 | $0.00 | |
| 90674 | 71 | 41 | $0.00 |